HIGHLIGHTS
- who: Peter P. Rainer from the ru00e9gu00e9nu00e9ratrice (RNM), France Hacettepe University, Turkey have published the research work: Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer, in the Journal: (JOURNAL)
- what: The authors examined the utility of LVEF and cardiac biomarkers hs-cTnT and NT-proBNP for dynamic assessment of cardiotoxicity risk in women with HER2+ eBC undergoing trastuzumab-based therapy.
- future: Statistical extensions of the joint model to define patient-specific optimal spacing of follow-up intervals based on a longitudinal biomarker trajectory have been . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.